🇺🇸 FDA
Patent

US 9804163

Biomarkers for prostate cancer and methods for their detection

granted A61KA61K2039/5252A61K2039/5256

Quick answer

US patent 9804163 (Biomarkers for prostate cancer and methods for their detection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/5252, A61K2039/5256, A61K2039/545, A61K2039/55583